MENU
EDIT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Editas Medicine (EDIT) Ownership - Who owns Editas Medicine?
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
265
Web
https://www.editasmedicine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
134.77M
P/E Ratio
N/A
Total Cash
269.91M
Projected Growth
N/A
Total Debt
35.03M
Revenue
32.31M
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash/Share
3.22
Total Debt/Equity
N/A
Revenue/Share
0.39 USD as % of share price
Fundamentals
EDIT
Capitalization
135M
P/E Ratio
N/A
Risk (Beta)
2.02
Dividend Yield
N/A
Total Cash
270M
Total Cash/Share
3.22
Total Debt
35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.39%
Revenue
32.3M
ROE
N/A
Book Value
134M
P/B Ratio
0.97
Cash Flow
N/A
Earnings
-2.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
3.75
Current Revenue Per Employee
2269.91
Dividends Per Share - Security
N/A
EBITDA
-233.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-56.40
Shares Held By Institutions
656M
Shares Outstanding - Current
83.7M
Total Liabilities
207M
Total Volume MTD
N/A
Value
1
Gain YTD
22.835
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which translates genome editing technology into a novel class of human therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
265
Web
https://www.editasmedicine.com